Univariate and multivariate Cox regression analyses to identify independent predictors of AKI by KDIGObin, NT0.5, and NT2×
AKI criteria predictorsa | Univariate analysis (HR [95% CI]) | P valueb | Multivariate (HR [95% CI]) | P valueb |
---|---|---|---|---|
KDIGObin | ||||
Age (yr) | 1.09 (1.00–1.02) | 0.143 | ||
Deoxycholate preparation | 1.15 (0.72–1.83) | 0.569 | ||
ICU initiation | 1.20 (0.71–2.03) | 0.497 | ||
Leishmaniasis | 1.10 (0.71–1.70) | 0.679 | ||
Charlson index ≥4 | 1.18 (0.37–3.77) | 0.776 | ||
Furosemide | 1.42 (0.91–2.21) | 0.127 | ||
ACE-I | 1.52 (0.93–2.50) | 0.095 | 1.53 (0.92–2.53) | 0.100 |
Polymyxin B | 0.73 (0.35–1.50) | 0.384 | ||
Vancomycin | 1.16 (0.77–1.76) | 0.466 | ||
Vasopressors | 1.10 (0.68–1.80) | 0.693 | ||
NT0.5 | ||||
Age (yr) | 1.01 (1.00–1.02) | 0.104 | 1.01 (1.00–1.04) | 0.084 |
Deoxycholate preparation | 1.68 (0.94–3.02) | 0.080 | ||
ICU initiation | 1.59 (0.91–2.77) | 0.102 | ||
Leishmaniasis | 0.83 (0.49–1.41) | 0.833 | ||
Charlson index ≥4 | 1.07 (0.63–1.83) | 0.793 | ||
Furosemide | 1.52 (0.92–2.51) | 0.101 | ||
ACE-I | 1.29 (0.73–2.28) | 0.374 | ||
Polymyxin B | 0.92 (0.42–2.00) | 0.826 | ||
Vancomycin | 1.70 (1.07–2.69) | 0.024 | 1.76 (1.10–2.78) | 0.018 |
Vasopressors | 1.45 (0.86–2.45) | 0.162 | ||
NT2× | ||||
Age (yr) | 1.00 (0.98–1.02) | 0.889 | ||
Deoxycholate preparation | 2.00 (0.89–4.48) | 0.092 | ||
ICU initiation | 2.07 (1.17–4.01) | 0.031 | ||
Leishmaniasis | 0.51 (0.24–1.09) | 0.082 | ||
Charlson index ≥4 | 1.21 (0.63–2.34) | 0.571 | ||
Furosemide | 1.67 (0.89–3.14) | 0.112 | ||
ACE-I | 1.50 (0.74–3.02) | 0.261 | ||
Polymyxin B | 1.09 (0.43–2.77) | 0.853 | ||
Vancomycin | 2.39 (1.32–4.33) | 0.004 | 2.00 (1.08–3.71) | 0.028 |
Vasopressors | 2.58 (1.41–4.71) | 0.002 | 2.08 (1.11–3.91) | 0.022 |